
    
      This is a Multicentre, Open label, Randomized, Two-arm, parallel-group study to assess
      efficacy and safety of EnvarsusÂ® compared with tacrolimus used as per current clinical
      practice in the initial maintenance setting in de novo kidney transplant patients. The study
      will be conducted in approximately 10 european countries.
    
  